Cleared Traditional

K894626 - EPSTEIN-BARR VIRUS-NUCLEAR ANTIGEN
(FDA 510(k) Clearance)

Oct 1989
Decision
88d
Days
Class 1
Risk

K894626 is an FDA 510(k) clearance for the EPSTEIN-BARR VIRUS-NUCLEAR ANTIGEN. This device is classified as a Test, Antigen, Nuclear, Epstein-barr Virus (Class I - General Controls, product code LLM).

Submitted by Bion Ent., Ltd. (Park Ridge, US). The FDA issued a Cleared decision on October 16, 1989, 88 days after receiving the submission on July 20, 1989.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K894626 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 20, 1989
Decision Date October 16, 1989
Days to Decision 88 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code LLM — Test, Antigen, Nuclear, Epstein-barr Virus
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235

Similar Devices — LLM Test, Antigen, Nuclear, Epstein-barr Virus

All 26
ADVIA Centaur EBV-EBNA IgG
K233605 · Biokit, S.A. · Aug 2024
DIASORIN LIAISON EBNA IGG, LIAISON VCA IGG, LIAISON VCA IGM ASSAYS
K040120 · DiaSorin, Inc. · Apr 2005
THE APTUS (AUTOMATED) APPLICATION OF THE EBNA IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR TH
K984133 · Zeus Scientific, Inc. · Jan 1999
IMMUNOWELL EBNA IGG TEST
K973941 · Genbio · Aug 1998
EBNA-1 IGM ELISA TEST SYSTEM
K980598 · Clark Laboratories, Inc. · May 1998
EBNA IGG EIA TEST SYSTEM
K951549 · Immunoprobe, Inc. · Apr 1996